CY1121063T1 - Αναστολεις της συνθασης της αλδοστερονης - Google Patents
Αναστολεις της συνθασης της αλδοστερονηςInfo
- Publication number
- CY1121063T1 CY1121063T1 CY181100920T CY181100920T CY1121063T1 CY 1121063 T1 CY1121063 T1 CY 1121063T1 CY 181100920 T CY181100920 T CY 181100920T CY 181100920 T CY181100920 T CY 181100920T CY 1121063 T1 CY1121063 T1 CY 1121063T1
- Authority
- CY
- Cyprus
- Prior art keywords
- compounds
- aldosterone
- inhibitors
- composition
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται σε ενώσεις του τύπου (I): και φαρμακευτικώς αποδεκτά άλατα αυτής, όπου τα Cy, R1 και R2 είναι όπως ορίζονται εδώ. Η εφεύρεση αναφέρεται επίσης σε φαρμακευτικές συνθέσεις περιλαμβάνουσες αυτές τις ενώσεις, σε μεθόδους χρησιμοποίησης αυτών των ενώσεων στη θεραπευτική αγωγή διάφοροι νόσων και διαταραχών, σε διεργασίες για την παρασκευή αυτών των ενώσεων και σε ενδιάμεσα χρήσιμα σε αυτές τις διεργασίες.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462028556P | 2014-07-24 | 2014-07-24 | |
PCT/US2015/041648 WO2016014736A1 (en) | 2014-07-24 | 2015-07-23 | Aldosterone synthase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1121063T1 true CY1121063T1 (el) | 2019-12-11 |
Family
ID=53761616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY181100920T CY1121063T1 (el) | 2014-07-24 | 2018-09-04 | Αναστολεις της συνθασης της αλδοστερονης |
Country Status (34)
Country | Link |
---|---|
US (1) | US9334285B2 (el) |
EP (1) | EP3172212B1 (el) |
JP (1) | JP6250862B2 (el) |
KR (1) | KR102378648B1 (el) |
CN (1) | CN106488921B (el) |
AP (1) | AP2016009616A0 (el) |
AR (1) | AR101290A1 (el) |
AU (1) | AU2015292632B2 (el) |
BR (1) | BR112017000584B1 (el) |
CA (1) | CA2956118C (el) |
CL (1) | CL2017000040A1 (el) |
CO (1) | CO2017000443A2 (el) |
CY (1) | CY1121063T1 (el) |
DK (1) | DK3172212T3 (el) |
EA (1) | EA031105B1 (el) |
ES (1) | ES2684050T3 (el) |
HR (1) | HRP20181441T1 (el) |
HU (1) | HUE039981T2 (el) |
IL (1) | IL249665B (el) |
LT (1) | LT3172212T (el) |
MX (1) | MX368093B (el) |
MY (1) | MY191352A (el) |
NZ (1) | NZ727188A (el) |
PE (1) | PE20170294A1 (el) |
PH (1) | PH12017500089A1 (el) |
PL (1) | PL3172212T3 (el) |
PT (1) | PT3172212T (el) |
RS (1) | RS57570B1 (el) |
SG (1) | SG11201700595RA (el) |
SI (1) | SI3172212T1 (el) |
TW (1) | TWI600658B (el) |
UA (1) | UA118801C2 (el) |
UY (1) | UY36228A (el) |
WO (1) | WO2016014736A1 (el) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL3207039T3 (pl) * | 2014-10-15 | 2019-08-30 | Boehringer Ingelheim International Gmbh | Inhibitory syntazy aldosteronu |
EP3227300B1 (en) * | 2014-12-02 | 2019-06-19 | Boehringer Ingelheim International GmbH | Aldosterone synthase inhibitors |
EP3475262B1 (en) | 2016-06-28 | 2021-03-24 | Boehringer Ingelheim International GmbH | Bicyclic imidazole derivatives useful for the treatment of renal disease, cardiovascular diseases and fibrotic disorders |
SG10201610038SA (en) * | 2016-07-29 | 2017-12-28 | Apple Inc | Systems and methods for management of asymmetrical multi-tapped battery packs |
US11958818B2 (en) | 2019-05-01 | 2024-04-16 | Boehringer Ingelheim International Gmbh | (R)-(2-methyloxiran-2-yl)methyl 4-bromobenzenesulfonate |
CN118401241A (zh) * | 2021-12-14 | 2024-07-26 | 勃林格殷格翰国际有限公司 | 用于治疗慢性肾脏病的醛固酮合成酶抑制剂 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100703068B1 (ko) * | 2003-12-30 | 2007-04-05 | 에스케이케미칼주식회사 | 피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물 |
RU2008142600A (ru) * | 2006-03-29 | 2010-05-10 | Новартис АГ (CH) | Органическое соединение |
TW200808813A (en) * | 2006-04-12 | 2008-02-16 | Speedel Experimenta Ag | Imidazo compounds |
AR092289A1 (es) * | 2011-11-14 | 2015-04-15 | Sunshine Lake Pharma Co Ltd | Derivados de aminoquinazolina y sus sales y metodos de uso |
US8912341B2 (en) * | 2013-01-16 | 2014-12-16 | Northwestern University | Enantioselective N-heterocyclic carbene-catalyzed annulation reactions with imidazolidinones |
-
2015
- 2015-07-23 EP EP15744459.7A patent/EP3172212B1/en active Active
- 2015-07-23 US US14/806,706 patent/US9334285B2/en active Active
- 2015-07-23 AP AP2016009616A patent/AP2016009616A0/en unknown
- 2015-07-23 UA UAA201701595A patent/UA118801C2/uk unknown
- 2015-07-23 TW TW104123931A patent/TWI600658B/zh active
- 2015-07-23 PE PE2017000086A patent/PE20170294A1/es unknown
- 2015-07-23 NZ NZ727188A patent/NZ727188A/en unknown
- 2015-07-23 PT PT15744459T patent/PT3172212T/pt unknown
- 2015-07-23 ES ES15744459.7T patent/ES2684050T3/es active Active
- 2015-07-23 PL PL15744459T patent/PL3172212T3/pl unknown
- 2015-07-23 CN CN201580036596.3A patent/CN106488921B/zh active Active
- 2015-07-23 WO PCT/US2015/041648 patent/WO2016014736A1/en active Application Filing
- 2015-07-23 JP JP2017503920A patent/JP6250862B2/ja active Active
- 2015-07-23 MX MX2017000929A patent/MX368093B/es active IP Right Grant
- 2015-07-23 EA EA201790253A patent/EA031105B1/ru not_active IP Right Cessation
- 2015-07-23 CA CA2956118A patent/CA2956118C/en active Active
- 2015-07-23 HU HUE15744459A patent/HUE039981T2/hu unknown
- 2015-07-23 SI SI201530354T patent/SI3172212T1/sl unknown
- 2015-07-23 MY MYPI2016002216A patent/MY191352A/en unknown
- 2015-07-23 AU AU2015292632A patent/AU2015292632B2/en active Active
- 2015-07-23 KR KR1020177005181A patent/KR102378648B1/ko active IP Right Grant
- 2015-07-23 AR ARP150102340A patent/AR101290A1/es active IP Right Grant
- 2015-07-23 RS RS20180970A patent/RS57570B1/sr unknown
- 2015-07-23 DK DK15744459.7T patent/DK3172212T3/en active
- 2015-07-23 LT LTEP15744459.7T patent/LT3172212T/lt unknown
- 2015-07-23 SG SG11201700595RA patent/SG11201700595RA/en unknown
- 2015-07-23 BR BR112017000584-0A patent/BR112017000584B1/pt active IP Right Grant
- 2015-07-24 UY UY0001036228A patent/UY36228A/es active IP Right Grant
-
2016
- 2016-12-20 IL IL249665A patent/IL249665B/en active IP Right Grant
-
2017
- 2017-01-06 CL CL2017000040A patent/CL2017000040A1/es unknown
- 2017-01-13 PH PH12017500089A patent/PH12017500089A1/en unknown
- 2017-01-19 CO CONC2017/0000443A patent/CO2017000443A2/es unknown
-
2018
- 2018-09-04 CY CY181100920T patent/CY1121063T1/el unknown
- 2018-09-07 HR HRP20181441TT patent/HRP20181441T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121706T1 (el) | Ενωσεις υποκατασταθεισες διυδροϊσοκινολινονης | |
CY1122610T1 (el) | Αλκοξυ πυραζολια ως ενεργοποιητες διαλυτης γουανυλικης κυκλασης | |
CY1121063T1 (el) | Αναστολεις της συνθασης της αλδοστερονης | |
CY1123627T1 (el) | Παραγωγα διυδροϊμιδαζοπυραζινονης χρησιμα στη θεραπευτικη αντιμετωπιση του καρκινου | |
CY1126109T1 (el) | Αναστολεις toy trpc6 | |
CY1118379T1 (el) | Αναστολεις ιου ηπατιτιδας c | |
EA201891103A1 (ru) | Композиции для лечения спинальной мышечной атрофии | |
CY1118678T1 (el) | Παραγωγα καρβοξαμιδιου χλωρο-πυραζινης χρησιμα για την θεραπευτικη αντιμετωπιση ασθενειων που ευνοουνται απο την ανεπαρκη ενυδατωση του βλεννογονου | |
EA202090486A3 (ru) | Соединения для лечения спинальной мышечной атрофии | |
EA201691940A1 (ru) | Новые соединения | |
MX2016013689A (es) | Compuestos 4-amino-imidazoquinolina. | |
MD20160106A2 (ro) | Compuşi aril sau heteroaril biciclici condensaţi şi utilizarea acestora ca inhibitori IRAK4 | |
EA201790246A1 (ru) | Гетероциклические карбоновые кислоты в качестве активаторов растворимой гуанилатциклазы | |
EA201691803A1 (ru) | Ингибиторы калликреина плазмы человека | |
EA201500383A1 (ru) | Производные 1,2,4-триазина для лечения вирусных инфекций | |
CY1121650T1 (el) | Αναστολεις συνθασης αλδοστερονης | |
DOP2017000034A (es) | Compuestos de imidazopiridazina | |
CY1123494T1 (el) | Enωσeiς etepoapyλo-kapboξamiδioy ως anaσtoλeiς thς ripk2 | |
EA201792264A1 (ru) | Способы лечения воспалительных заболеваний | |
EA201700356A1 (ru) | Новые циклопропанбензофуранилпиридопиразиндионы | |
CY1120608T1 (el) | Φαρμακευτικως δραστικες ενωσεις | |
EA201650003A1 (ru) | Соединённые циклоалкилом дигетероциклические производные | |
EA201691796A1 (ru) | П-замещенные асимметричные мочевины и их применение в медицине | |
WO2015198263A3 (en) | Novel betulinic proline substituted derivatives as hiv inhibitors | |
EA201400786A1 (ru) | Карбоциклические нуклеозиды, их фармацевтическое применение и композиции |